2,5-dihydroxybenzoic acid has been researched along with technetium tc 99m exametazime in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballinger, JR; Ecclestone, M; Gerson, B; Gulenchyn, KY; Proulx, A; Reid, RH | 1 |
Barber, RW; Sampson, CB; Solanki, C; Wraight, EP | 1 |
2 other study(ies) available for 2,5-dihydroxybenzoic acid and technetium tc 99m exametazime
Article | Year |
---|---|
In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.
Topics: Costs and Cost Analysis; Gentisates; Humans; Hydroxybenzoates; In Vitro Techniques; Isotope Labeling; Leukocytes; Leukocytes, Mononuclear; Neutrophils; Organotechnetium Compounds; Oximes; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Exametazime | 1990 |
Seven-hour stabilization of 99Tcm-exametazime (HMPAO) for cerebral perfusion.
Topics: Butanones; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Costs and Cost Analysis; Drug Stability; Gentisates; Humans; Hydroxybenzoates; Indicators and Reagents; Nose; Radionuclide Imaging; Radiopharmaceuticals; Salivary Glands; Technetium Tc 99m Exametazime; Time Factors; United Kingdom | 1998 |